Cargando…
Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
BACKGROUND: It is now emerging that for vaccines against a range of diseases including influenza, malaria and HIV, the induction of a humoral response is insufficient and a substantial complementary cell-mediated immune response is necessary for adequate protection. Furthermore, for some diseases su...
Autores principales: | Agger, Else Marie, Rosenkrands, Ida, Hansen, Jon, Brahimi, Karima, Vandahl, Brian S., Aagaard, Claus, Werninghaus, Kerstin, Kirschning, Carsten, Lang, Roland, Christensen, Dennis, Theisen, Michael, Follmann, Frank, Andersen, Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2525815/ https://www.ncbi.nlm.nih.gov/pubmed/18776936 http://dx.doi.org/10.1371/journal.pone.0003116 |
Ejemplares similares
-
Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction
por: Wørzner, Katharina, et al.
Publicado: (2021) -
Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
por: Dietrich, Jes, et al.
Publicado: (2014) -
A Novel Liposome-Based Adjuvant CAF01 for Induction of CD8(+) Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice
por: Gram, Gregers Jacob, et al.
Publicado: (2009) -
CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
por: Martel, Cyril Jean-Marie, et al.
Publicado: (2011) -
Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis
por: Christensen, Dennis, et al.
Publicado: (2010)